KraneShares Emerging Markets Healthcare Index ETF (KMED) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
KraneShares Emerging Markets Healthcare Index ETF (KMED) trades at $18.81 with AI Score 44/100 (Grade C). KraneShares Emerging Markets Healthcare Index ETF (KMED) focuses on investing in companies within the emerging markets healthcare sector. Market cap: $2.00M, Sector: Financial services.
Price as of Aug 20, 2026 · Last analyzed: Mar 17, 2026Analyst Coverage for KMED: KMED does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates KMED against Financial Services peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
KMED: the 3 scored disciplines are evenly split. Dominant signal: Izzy Englander bullish.
How is this calculated? →Why this analysis is different
- A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
KraneShares Emerging Markets Healthcare Index ETF (KMED) Financial Services Profile
KraneShares Emerging Markets Healthcare Index ETF (KMED) provides targeted exposure to the emerging markets healthcare sector, encompassing pharmaceuticals, biotechnology, and healthcare services. As a non-diversified fund, KMED offers investors a focused approach to capitalize on the growth potential within emerging market healthcare industries, tracking a specialized underlying index.
What Is the Investment Thesis for KMED?
The KraneShares Emerging Markets Healthcare Index ETF (KMED) offers a focused investment in the rapidly expanding healthcare sector of emerging markets. With a beta of 0.66, KMED demonstrates lower volatility compared to the broader market, potentially offering a degree of downside protection. The primary value driver is the increasing demand for healthcare services and products in emerging economies, fueled by rising incomes and aging populations. Growth catalysts include advancements in medical technology and expanding access to healthcare in these regions. However, potential risks include regulatory changes, currency fluctuations, and geopolitical instability impacting emerging markets.
Based on FMP financials and quantitative analysis
KMED Key Highlights
KMED focuses on the emerging markets healthcare sector, providing targeted exposure to a high-growth area.
- The fund invests at least 80% of its net assets in instruments included in its underlying index, ensuring close tracking of the target market.
- KMED's underlying index includes companies engaged in pharmaceuticals, biotechnology, medical specialties, and healthcare services, offering diversified exposure within the healthcare sector.
- The fund is non-diversified, allowing for concentrated investments in promising companies within the emerging markets healthcare space.
- KMED has a beta of 0.66, indicating lower volatility compared to the broader market.
Who Are KMED's Competitors?
KMED is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ALISR Calisa Acquisition Corp Right | $0.64 | +0.00% | 79 | |
| IDKFF ThreeD Capital Inc. | $0.07 | +13.85% | $6.98M | 70 |
| ALTEX Firsthand Alternative Energy Fund | $12.93 | -1.90% | $8.98M | 82 |
| BCG Binah Capital Group, Inc. | $1.40 | +0.72% | $23.5M | 78 |
| EEA The European Equity Fund, Inc. | $11.15 | -0.59% | $74.7M | 67 |
| HNNA Hennessy Advisors, Inc. | $9.89 | -1.30% | $78.2M | 81 |
| ETHT ProShares - Ultra Ether ETF | $12.57 | +19.94% | $92.2M | 68 |
| TPZ Tortoise Electrification Infrastructure ETF | $21.62 | -0.18% | $127M | 70 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are KMED's Key Strengths?
Targeted exposure to the high-growth emerging markets healthcare sector.
- Transparent and rules-based investment approach through index tracking.
- Lower volatility compared to the broader market, as indicated by a beta of 0.66.
- Specialized focus differentiates it from broader emerging market ETFs.
What Are KMED's Weaknesses?
Non-diversified structure increases concentration risk.
- Performance is highly dependent on the performance of the emerging markets healthcare sector.
- Subject to currency fluctuations and geopolitical risks in emerging markets.
- May have higher expense ratios compared to broader market ETFs.
What Could Drive KMED Stock Higher?
Increasing healthcare spending in emerging markets driven by economic growth.
- Advancements in medical technology and innovation in emerging economies.
- Government initiatives to improve healthcare access and quality in emerging markets.
What Are the Key Risks for KMED?
Regulatory changes and policy risks in emerging markets impacting healthcare companies.
- Currency fluctuations and geopolitical instability affecting emerging market investments.
- Economic slowdowns in emerging economies reducing healthcare spending.
- Competition from other ETFs and investment products targeting the healthcare sector.
What Are the Growth Opportunities for KMED?
- Expanding Healthcare Access in Emerging Markets: As emerging economies develop, access to healthcare services and products is increasing, driving demand for healthcare companies. This expansion is supported by government initiatives and rising incomes, creating a significant growth opportunity for companies within KMED's underlying index. Timeline: Ongoing.
- Advancements in Medical Technology and Innovation: Emerging markets are increasingly adopting advanced medical technologies and innovations, leading to growth in the biotechnology and pharmaceutical sectors. Companies within KMED's underlying index are at the forefront of developing and implementing these technologies, positioning them for significant growth. Timeline: Ongoing.
- Aging Populations in Emerging Economies: Many emerging markets are experiencing aging populations, which is driving increased demand for healthcare services and products. This demographic shift creates a long-term growth opportunity for companies within KMED's underlying index, particularly those focused on geriatric care and related services. The market for geriatric care in emerging markets is projected to grow substantially in the coming decades. Timeline: Ongoing.
- Increasing Healthcare Spending in Emerging Markets: Healthcare spending in emerging markets is rising rapidly, driven by economic growth and government investments in healthcare infrastructure. This increased spending is benefiting companies within KMED's underlying index, leading to higher revenues and profits. Timeline: Ongoing.
- Government Support for Healthcare Development: Governments in emerging markets are increasingly prioritizing healthcare development, implementing policies and initiatives to improve healthcare access and quality. This support is creating a favorable environment for companies within KMED's underlying index, fostering growth and innovation. Government investments in healthcare infrastructure and research are expected to continue, driving further growth in the sector. Timeline: Ongoing.
What Are KMED's Competitive Advantages?
- Specialized Focus: KMED's focus on emerging markets healthcare provides a unique offering in the ETF market.
- Index Tracking: The fund's strategy of tracking a specific index offers transparency and rules-based investing.
- Brand Recognition: KraneShares is a well-known brand in the ETF industry, providing credibility and trust.
What Does KMED Do?
KraneShares Emerging Markets Healthcare Index ETF (KMED) is designed to provide investors with exposure to companies operating in the healthcare sector within emerging markets. The fund invests at least 80% of its net assets in instruments included in its underlying index, which comprises companies classified by RBICS as being involved in pharmaceuticals, biotechnology, medical specialties, managed health care, hospital/nursing management, medical/nursing services, and services to the health industry. KMED is structured as a non-diversified fund, meaning it can invest a larger portion of its assets in a smaller number of issuers compared to a diversified fund. This concentration can potentially lead to higher returns but also carries increased risk. The fund aims to capture the growth potential of the emerging markets healthcare sector by focusing on companies that are directly involved in providing healthcare products and services. By tracking a specific index, KMED offers a transparent and rules-based approach to investing in this dynamic market segment. The fund's strategy is geared towards investors seeking targeted exposure to the emerging markets healthcare industry, with an emphasis on companies that are driving innovation and growth in the sector. KMED's investment approach is passive, seeking to replicate the performance of its underlying index rather than actively selecting individual stocks.
What Products and Services Does KMED Offer?
- Invests in companies engaged in the pharmaceuticals industry within emerging markets.
- Provides exposure to the biotechnology sector in developing economies.
- Targets companies involved in medical specialties across emerging markets.
- Includes firms focused on managed health care in developing nations.
- Covers hospital and nursing management companies in emerging economies.
- Invests in medical and nursing services providers within emerging markets.
- Offers exposure to companies providing services to the health industry in developing countries.
How Does KMED Make Money?
- KMED generates revenue through management fees charged to investors.
- The fund's performance is tied to the performance of its underlying index, which tracks emerging markets healthcare companies.
- KMED's business model is based on providing investors with targeted exposure to a specific sector within emerging markets.
What Industry Does KMED Operate In?
The asset management industry is evolving rapidly, driven by technological advancements, changing investor preferences, and increasing regulatory scrutiny. ETFs like KMED play a significant role by offering targeted exposure to specific sectors and geographies. The competitive landscape includes both large, established asset managers and smaller, specialized firms. KMED differentiates itself by focusing specifically on the emerging markets healthcare sector, capitalizing on the growth potential of healthcare industries in developing economies. This targeted approach allows investors to gain exposure to a niche market segment with unique growth drivers.
Who Are KMED's Key Customers?
- Institutional investors seeking exposure to emerging markets healthcare.
- Retail investors interested in targeted sector-specific investments.
- Financial advisors looking for specialized investment products for their clients.
KraneShares Emerging Markets Healthcare Index ETF (KMED) Valuation Context
Valued at $2.00M, KMED is classified as a micro-cap stock. Relative to its peer group, KMED's quantitative score of 44/100 is below the peer average of 75/100.
Key Financial Metrics
Return on equity for KraneShares Emerging Markets Healthcare Index ETF stands at 0.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 0.0%, showing how much profit it generates from its asset base. KMED trades at a trailing price-to-earnings ratio of 0.00, below the Financial Services sector average of ~18x. Its free cash flow yield is 0.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 0.0%, the inverse of the P/E and a quick read on earnings relative to price.
KMED Financials
Bull Case vs Bear Case
Bull Case
- Recent insider buying activity suggests strong confidence in KMED's future performance, indicating that those closest to the company believe in its growth potential.
- Community sentiment has shifted positively, with discussions highlighting the increasing demand for healthcare in emerging markets, which KMED targets.
- Market perception has been bolstered by favorable regulatory developments in key emerging economies, enhancing the investment landscape for healthcare.
- Investors are increasingly recognizing the potential of healthcare ETFs as a hedge against economic uncertainty, driving interest in KMED.
Bear Case
- Concerns over geopolitical tensions in emerging markets have led to heightened risk aversion, which could negatively impact KMED's performance.
- Some community members express skepticism about the sustainability of growth in emerging markets, particularly in the healthcare sector, reflecting broader economic uncertainties.
- Recent discussions have highlighted the volatility in emerging markets, which may deter cautious investors from committing to KMED.
- The ETF's performance has been compared unfavorably to more established markets, leading to doubts about its competitive edge in a crowded space.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · April 2026
KMED Latest News
No recent news available for KMED.
KMED Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for KMED.
Price Targets
Wall Street price target analysis for KMED.
KMED MoonshotScore
What does this score mean?
The MoonshotScore rates KMED 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
KraneShares Emerging Markets Healthcare Index ETF Financial Services Stock: Key Questions Answered
What does the AI Score mean for KMED?
KMED holds an AI Score of 44/100 (Grade: C). This is an educational research signal, not a buy or sell recommendation. KraneShares Emerging Markets Healthcare Index ETF (KMED) focuses on investing in companies within the emerging markets healthcare sector. The fund tracks an index composed of companies engaged …
What does KraneShares Emerging Markets Healthcare Index ETF do?
KraneShares Emerging Markets Healthcare Index ETF (KMED) is designed to provide investors with targeted exposure to the healthcare sector within emerging markets. The fund invests in companies engaged in pharmaceuticals, biotechnology, medical specialties, managed health care, and related services.
What are the main risks for KMED?
The main risks for KMED include regulatory changes in emerging markets that could impact healthcare companies, currency fluctuations that can affect investment returns, and geopolitical instability that can disrupt economic activity. Additionally, competition from other ETFs and investment products targeting the healthcare sector poses a risk.
What are the key factors to evaluate for KMED?
KraneShares Emerging Markets Healthcare Index ETF (KMED) holds an AI score of 44/100 (low). The KraneShares Emerging Markets Healthcare Index ETF (KMED) offers a focused investment in the rapidly expanding healthcare sector of emerging markets. Not financial advice.
How frequently does KMED data refresh on this page?
KMED's price was last updated on Aug 20, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven KMED's recent stock price performance?
KraneShares Emerging Markets Healthcare Index ETF (KMED) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Targeted exposure to the high-growth emerging markets healthcare sector. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider KMED overvalued or undervalued right now?
KraneShares Emerging Markets Healthcare Index ETF (KMED) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research KMED before investing?
Before investing in KraneShares Emerging Markets Healthcare Index ETF (KMED), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding KMED to a portfolio?
Key strength of KraneShares Emerging Markets Healthcare Index ETF (KMED): Targeted exposure to the high-growth emerging markets healthcare sector. Weigh rewards against risks and diversify. Not financial advice.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- AI analysis pending for KMED, limiting the depth of available insights.
- Emerging markets investments carry inherent risks related to political and economic instability.